NGEN · Company research
NervGen Pharma Corp. Common stock (NGEN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| NGEN Feb 2027 5.000 call (NGEN270219C00005000) stock historical prices and data - Yahoo Finance UK | NGEN Feb 2027 5.000 call (NGEN270219C00005000) stock historical prices and data Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 17, 2026 | neutral | 0 | 0.6 |
| NGEN Feb 2027 5.000 call (NGEN270219C00005000) interactive stock chart - Yahoo Finance UK | NGEN Feb 2027 5.000 call (NGEN270219C00005000) interactive stock chart Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 17, 2026 | neutral | 0 | 0.6 |
| NGEN Jan 2027 5.000 call (NGEN270115C00005000) stock price, news, quote and history - Yahoo Finance UK | NGEN Jan 2027 5.000 call (NGEN270115C00005000) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 17, 2026 | neutral | 0 | 0.6 |
| NGEN Jan 2027 2.500 call (NGEN270115C00002500) Stock Price, News, Quote & History - Yahoo! Finance Canada | NGEN Jan 2027 2.500 call (NGEN270115C00002500) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| A spinal cord injury drug enters late-stage testing to assess hand function and quality of life. - Stock Titan | A spinal cord injury drug enters late-stage testing to assess hand function and quality of life. Stock Titan | View source ↗ | Stock Titan | Oct 12, 2026 | neutral | 0 | 0.6 |
| NGEN Feb 2027 5.000 call (NGEN270219C00005000) Stock Historical Prices & Data - Yahoo! Finance Canada | NGEN Feb 2027 5.000 call (NGEN270219C00005000) Stock Historical Prices & Data Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 10, 2026 | neutral | 0 | 0.6 |
| NGEN Feb 2027 5.000 call (NGEN270219C00005000) stock price, news, quote and history - Yahoo Finance UK | NGEN Feb 2027 5.000 call (NGEN270219C00005000) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 9, 2026 | neutral | 0 | 0.6 |
| Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), United Therapeutics (UTHR) and NervGen Pharma (NGEN) - The Globe and Mail | Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), United Therapeutics (UTHR) and NervGen Pharma (NGEN) The Globe and Mail | View source ↗ | The Globe and Mail | Oct 2, 2026 | neutral | 0 | 0.6 |
| NervGen Pharma: The Upside Is Large, But Phase 3 Decides Everything (NASDAQ:NGEN) - Seeking Alpha | NervGen Pharma: The Upside Is Large, But Phase 3 Decides Everything (NASDAQ:NGEN) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 1, 2026 | neutral | 0 | 0.6 |
| NervGen Pharma (Nasdaq:NGEN) - Stock Analysis - Simply Wall Street | NervGen Pharma (Nasdaq:NGEN) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Sep 30, 2026 | neutral | 0 | 0.6 |
| NervGen Pharma Corp. (NGEN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade | NervGen Pharma Corp. (NGEN) Stock Price | Live Quotes & Charts | NASDAQ StocksToTrade | View source ↗ | StocksToTrade | Sep 23, 2026 | neutral | 0 | 0.6 |
| Four experts join a live spinal cord research webcast - Stock Titan | Four experts join a live spinal cord research webcast Stock Titan | View source ↗ | Stock Titan | Sep 9, 2026 | neutral | 0 | 0.6 |
| H.C. Wainwright cuts NervGen stock price target to $15 on dilution - Investing.com | H.C. Wainwright cuts NervGen stock price target to $15 on dilution Investing.com | View source ↗ | Investing.com | Jul 14, 2026 | neutral | 0 | 0.6 |
| NervGen Pharma: I Think The Biggest Risks Are Now Behind It (NASDAQ:NGEN) - Seeking Alpha | NervGen Pharma: I Think The Biggest Risks Are Now Behind It (NASDAQ:NGEN) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 2, 2026 | neutral | 0 | 0.6 |
| NGEN Stock Price and Chart — NASDAQ:NGEN - TradingView | NGEN Stock Price and Chart — NASDAQ:NGEN TradingView | View source ↗ | TradingView | May 28, 2026 | neutral | 0 | 0.6 |
| NGEN Slides As NervGen Pharma Dilution Hits Share Price - www.timothysykes.com | NGEN Slides As NervGen Pharma Dilution Hits Share Price www.timothysykes.com | View source ↗ | www.timothysykes.com | May 24, 2026 | neutral | 0 | 0.6 |
| NervGen Pharma Corp. Announces Pricing for $60 Million Underwritten Public Offering of Common Shares and Warrants | NGEN Stock News - Quiver Quantitative | NervGen Pharma Corp. Announces Pricing for $60 Million Underwritten Public Offering of Common Shares and Warrants | NGEN Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | May 22, 2026 | neutral | 0 | 0.6 |
| What is the current Price Target and Forecast for NervGen Pharma Corp. (NGEN) - Zacks Investment Research | What is the current Price Target and Forecast for NervGen Pharma Corp. (NGEN) Zacks Investment Research | View source ↗ | Zacks Investment Research | Apr 29, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Jan 9, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.